Luo, Suxia

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4

Qin, S., Xu, L., Yi, M., Yu, S., Wu, K., & Luo, S. (2019) · Molecular Cancer

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 1,145

Regulation of PD-L1 expression in the tumor microenvironment

Yi, M., Niu, M., Xu, L., Luo, S., & Wu, K. (2021) · Journal of Hematology & Oncology

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 681

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1

Yi, M., Zhang, J., Li, A., Niu, M., Yan, Y., Jiao, Y., Luo, S., Zhou, P., & Wu, K. (2021) · Journal of Hematology & Oncology

Cancer Immunotherapy and BiomarkersTGF-β signaling in diseases

Cited by 233

The role of cancer-derived microRNAs in cancer immune escape

Yi, M., Xu, L., Jiao, Y., Luo, S., Li, A., & Wu, K. (2020) · Journal of Hematology & Oncology

MicroRNA in disease regulationCancer Immunotherapy and Biomarkers

Cited by 221

Prospects for combining immune checkpoint blockade with PARP inhibition

Li, A., Yi, M., Qin, S., Chu, Q., Luo, S., & Wu, K. (2019) · Journal of Hematology & Oncology

Cancer Immunotherapy and BiomarkersPARP inhibition in cancer therapy

Cited by 143

Advances and perspectives of PARP inhibitors

Yi, M., Dong, B., Qin, S., Chu, Q., Wu, K., & Luo, S. (2019) · Experimental Hematology & Oncology

PARP inhibition in cancer therapyDNA Repair Mechanisms

Cited by 117

The biology of combination immunotherapy in recurrent metastatic head and neck cancer

Yuan, X., Yi, M., Zhang, W., Xu, L., Chu, Q., Luo, S., & Wu, K. (2021) · The International Journal of Biochemistry & Cell Biology

Cancer Immunotherapy and BiomarkersHead and Neck Cancer Studies

Cited by 13

Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials

Li, J., Wang, Z., Huang, J., Ba, Y., Cao, B., Luo, S., Li, W., Bai, C., Song, Z., Xiong, J., et al. (2026) · The Lancet Gastroenterology & Hepatology

Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations

Cited by 3